XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 174 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,935,381 | -30.6% | 413,906 | -35.4% | 0.27% | -36.1% |
| Q1 2023 | $22,948,548 | -9.2% | 641,200 | 0.0% | 0.42% | -15.6% |
| Q4 2022 | $25,282,516 | +9.2% | 641,200 | 0.0% | 0.50% | +9.7% |
| Q3 2022 | $23,147,000 | +62.0% | 641,200 | +36.5% | 0.46% | +48.7% |
| Q2 2022 | $14,288,000 | -48.5% | 469,700 | -68.5% | 0.31% | -18.0% |
| Q2 2021 | $27,744,000 | +4.0% | 1,490,000 | 0.0% | 0.37% | -5.6% |
| Q1 2021 | $26,671,000 | +68.3% | 1,490,000 | +44.6% | 0.40% | +62.6% |
| Q4 2020 | $15,844,000 | +12.3% | 1,030,140 | -19.1% | 0.24% | -12.0% |
| Q3 2020 | $14,104,000 | -11.7% | 1,274,100 | 0.0% | 0.28% | -20.5% |
| Q2 2020 | $15,977,000 | +10.6% | 1,274,100 | 0.0% | 0.35% | -25.9% |
| Q1 2020 | $14,448,000 | -13.5% | 1,274,100 | 0.0% | 0.47% | -0.6% |
| Q4 2019 | $16,703,000 | +45.5% | 1,274,100 | 0.0% | 0.47% | +24.3% |
| Q3 2019 | $11,480,000 | -8.6% | 1,274,100 | 0.0% | 0.38% | -0.8% |
| Q2 2019 | $12,563,000 | +99.2% | 1,274,100 | +105.3% | 0.38% | +76.0% |
| Q1 2019 | $6,306,000 | +135.5% | 620,691 | +46.2% | 0.22% | +82.4% |
| Q4 2018 | $2,678,000 | -35.6% | 424,433 | +34.7% | 0.12% | -22.2% |
| Q3 2018 | $4,158,000 | – | 315,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,760,853 | $183,292,841 | 2.31% |